Wacker Biotech and RNAV8 Bio have embarked on a transformative mRNA technology partnership, aiming to revolutionize medicine. Wacker Biotech brings advanced microbial fermentation capabilities, enhancing pharmaceutical protein and pDNA production.…
Relay Therapeutics is undergoing significant changes with workforce reductions and cost-cutting to focus on clinical ambitions. The company has reduced its annual research budget by 75% and cut 70 jobs…
The pharmaceutical industry's R&D is driven by a competitive pursuit of innovation and breakthroughs. Merck continues its prominence in oncology and vaccines, aiming for long-term impact through strategic R&D investment.…
The pharmaceutical and biotech sectors exhibited resilience amid broad economic turmoil, largely unaffected by sweeping tariffs. Companies like Catalyst Pharmaceuticals and Veeva Systems experienced only minor stock declines, while Amgen…
ERBC and Menarini Biotech have formed a strategic alliance to revolutionize early-stage biopharmaceutical development. This partnership bridges the gap between scientific research and clinical trials through combined expertise in non-clinical…
The biotech and pharmaceutical sectors are undergoing significant layoffs, driving strategic shifts and financial recalibrations. Companies like Nkarta and ElevateBio are reducing workforces to focus on core innovations and cost-effective…
The biotech and pharmaceutical industries face significant layoffs due to shifting priorities, financial challenges, and strategic realignments. Major companies like Nkarta, ElevateBio, Alector, and others are reducing their workforce to…
The biotech industry is on the brink of a resurgence, with innovations and strategic financial moves driving potential recovery. Jazz Pharmaceuticals stands out with groundbreaking work in neuroscience and oncology,…
Pelareorep is emerging as a promising treatment in difficult-to-treat cancers, igniting optimism in the medical community. The German Paul-Ehrlich-Institute approved full enrolment for Oncolytics Biotech's pancreatic cancer study combining pelareorep…
**Sana Biotechnology**, a biotech firm based in Seattle, has ignited excitement among investors and the medical community with promising early data from their innovative allogeneic cell therapy aimed at treating…